IP Library › Patent Application 19503181
Patent Application Utility PCT National Stage Small
App. No. 19/503,181 · Confirmation No. 2193

METHODS OF TREATING CHRONIC KIDNEY DISEASE (CKD) OR CKD AND HYPERTENSION WITH LORUNDROSTAT, OR A COMBINATION OF LORUNDROSTAT AND A SGLT2 INHIBITOR

Application Undergoing Preexam Processing
⬇ PDF
Code Description Pages PDF
2026-01-28 IDS Information Disclosure Statement (IDS) Form (SB08) 5 View
2026-01-28 REF.OTHER Other reference-Patent/Application/Search Documents 40 View
2026-01-28 N417 Electronic Filing System Acknowledgment Receipt 2 View
2026-01-16 A.PE Preliminary Amendment — View
2026-01-16 A.PE Preliminary Amendment 1 View
2026-01-16 SPEC Specification 1 View
2026-01-16 REM Applicant Arguments/Remarks Made in an Amendment 2 View
2026-01-16 ADS Application Data Sheet 9 View
2026-01-16 OATH Oath or Declaration filed 1 View
2026-01-16 R3.73 Assignee showing of ownership per 37 CFR 3.73 4 View
2026-01-16 TRNA Transmittal of New Application 5 View
2026-01-16 PA.. Power of Attorney 1 View
2026-01-16 IDS Information Disclosure Statement (IDS) Form (SB08) 5 View
2026-01-16 FOR Foreign Reference 66 View
2026-01-16 N417 Electronic Filing System Acknowledgment Receipt 4 View
2026-01-16 N417.PYMT Electronic Fee Payment 2 View
2026-01-16 FRPR Certified Copy of Foreign Priority Application 119 View
2026-01-16 P.N.101.CONV PCT/RO/101 - Request form for new International Application - Conventional 6 View
2026-01-16 371P Documents submitted with 371 (National Stage) Applications 1 View
2026-01-16 ABST Abstract 2 View
2026-01-16 FRPR Certified Copy of Foreign Priority Application 139 View
2026-01-16 SPEC Specification 99 View
2026-01-16 CLM Claims 18 View
2026-01-16 DRW Drawings-only black and white line drawings 2 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
19/503,181
Effective Filing
2026-01-16